AI assistant
Sending…
MADRIGAL PHARMACEUTICALS, INC. — Director's Dealing 2023
Jun 20, 2023
30608_dirs_2023-06-20_56bfc92c-6f4c-4d36-a1a0-fe27d5901ad0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK: 0001157601
Period of Report: 2023-06-15
Reporting Person: Cheong Raymond (Director)
More from MADRIGAL PHARMACEUTICALS, INC.
Interim / Quarterly Report
2026
May 6
Earnings Release
2026
May 6
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 24
Annual Report
2026
Feb 19
Earnings Release
2026
Feb 19
Regulatory Filings
2026
Jan 30
Director's Dealing
2026
Jan 26